A potent and selective small molecule inhibitor of the Aurora kinases suppresses tumour growth in vivo. Nature Medicine: 10, 262-267 (2004).
Harrington, E.A., Bebbington D., Moore J., Rasmussen R.K., Ajose-Adeogun A.O., Tomoko Nakayama T., Graham J.A., Demur C., Hercend T., Diu-Hercend A., Su M., Golec J.M.C., & Miller K.M. VX-680
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents. Biochem Pharmacol: 72(8), 941-948 (2006)
Coley, H.M., Shotten, C.F., Ajose-Adeogun, A., Modjtahedhi, H., & Thomas, H.
The UK National Cancer Research Institute (NCRI) Informatics Initiative: promoting partnership in cancer research. Human Mutat: 28 (12), 1151-11515 (2007)
Reddington, F., Ajose-Adeogun., A and Clark, R.
Race Bias Costing Lives, BBC Scrubbing Up Nov 2010
View Point by Abi Ajose-Adeogun and Marina Raime
The Voice and Keep The Faith on black women and breast cancer in 2010 and 2011
Authored articles for Nursing Standard News
African Caribbean Cancer Awareness and Outreach Community Based Assessment (2012).
A report for Paul’s Cancer Support Centre.
Understanding the Needs of Women With Fibroids.
Lake Health and Wellbeing (formerly known as The Lake Foundation), (2014).
Summary Report – The Lake Foundation’s Cancer Support Group.
Lake Health and Wellbeing (formerly known as The Lake Foundation), (2015).
Engagement and Empowerment Pilot: Exploring Whether Black Churches Are An Effective Environment For Raising Awareness.
Lake Health and Wellbeing (Formerly known as The Lake Foundation), (2015).